Home9966 • HKG
add
Alphamab Oncology
Previous close
$3.38
Day range
$3.29 - $3.39
Year range
$2.00 - $6.12
Market cap
3.20B HKD
Avg Volume
3.02M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 86.78M | 27.18% |
Operating expense | 114.58M | 0.54% |
Net income | -22.45M | -12.63% |
Net profit margin | -25.87 | 11.43% |
Earnings per share | — | — |
EBITDA | -27.81M | 43.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.46B | -7.90% |
Total assets | 2.14B | -8.00% |
Total liabilities | 513.25M | 6.58% |
Total equity | 1.63B | — |
Shares outstanding | 964.92M | — |
Price to book | 2.00 | — |
Return on assets | -5.04% | — |
Return on capital | -5.52% | — |
Cash Flow
Net change in cash
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -22.45M | -12.63% |
Cash from operations | -23.00M | 37.54% |
Cash from investing | 18.97M | 124.25% |
Cash from financing | 29.04M | -77.45% |
Net change in cash | 27.10M | -19.23% |
Free cash flow | -11.97M | 64.77% |
About
CEO
Founded
2008
Website
Employees
429